The Drug regulator of Japan, the Pharmaceuticals and Medical Devices Agency (PMDA) is set to open their office in India due to concerns over aging population and healthcare costs of branded drugs. This move of Japan’s drug regulator will help out the Indian generic drug manufacturers who are looking to expand their presence in Japan. Japan’s market worth is $110 billion and is the second largest market after US. To know more getting an manufacturing license in India you could visit –  Document required for obtaining manufacturing license in India.

By encouraging the generic drugs Japan looks to reduce the healthcare costs and Japan will double the generics share in their market by 2017-2018 which would be a great opportunity for the Indian drug manufacturers. An official said, “In the regulated Japanese market for decades the drug makers of India couldn’t do much but has high skills on producing efficient and affordable drugs”. READ ALSO: Why should you invest in India?